Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and,... see more

TSXV:MDX - Post Discussion

Medx Health Corp > BT Global Growth Monthly Report
View:
Post by Insightful1 on Mar 06, 2021 2:07am

BT Global Growth Monthly Report

Paul Beattie is a very successful fund manager at BT Global and has an investment in MedX according to his recent Monthly Reports.

Here are his comments on MedX this month.


A more striking comparable is the MedX Health Corp (MDX.v), with a market cap of C $40 mil. which will be bringing tele-dermatology to the world using special cameras and digitizing pictures of skin abnormalities. The US comparable is DermTech (DMTK) with a market cap of US $1.8 bil. and revenues of $5 mil. These are small indications of the value gap between our two countries’ equity markets. We are not claiming that these companies should trade at similar values, but simply pointing out the massive valuation discrepancies and the likelihood that the Canadian names will 
get US investor buying interest at one point, partially closing the gap.
Comment by hopefull on Mar 06, 2021 7:37am
That's awesome news. I guess the Americans are also waiting for news and actual sales and I would imagine we might see a share price bump.
Comment by Eastmk on Mar 06, 2021 8:45am
This has been my thinking all along. There is definitely a disconnect in the market that fails to recognize Medx's potential.  If you read through any of the marketing materials for DermTech, you will see that all of the facts in terms of the size of the melanoma detection market and the growth potential for for their technology is basically the same for Medx.  IMO a huge reason ...more  
Comment by Rubberband on Mar 06, 2021 11:39am
And the debt that Derm Tech is holding is ???. Medx has turned the page and we will see revenue on the books this year. Netherlands itself being a tiny piece of the puzzle should bring somewhere between 1.5-2,5 million of recurring cash. The world is opening slowly now. We all should start to hear more on Brazil and units being sent. We should hear more on other south american countries signing up ...more  
Comment by Dunworkin2 on Mar 06, 2021 2:15pm
...."just freaking relax"!!!....guote of the day, I'm relaxed Rubberband but want Mdx to excite me with some revenue announcements! :)) Still trying to understand our little rocket ship action without significant revenue news....puzzling me, but I'm chilled. 
Comment by hopefull on Mar 06, 2021 2:37pm
completely chilled. Would like to know what your definition is " coming and coming fast" is Because with this company nothing comes fast.
Comment by Swampcat27 on Mar 06, 2021 5:09pm
Once again hopefull, you have a valid point....
Comment by Swampcat27 on Mar 06, 2021 5:10pm
So. Thats 2 points for hopefull and 1 point for insightfull
Comment by Swampcat27 on Mar 06, 2021 5:11pm
Pardon me. Thats Insightful1.   my bad.
Comment by hopefull on Mar 06, 2021 5:25pm
thanks just being real and doing my dd
Comment by Rubberband on Mar 06, 2021 10:50pm
Well of all people Dunworkin, I know your relaxed by your comment. I am not sure how and why people are so worried about why MDX has had a large jump these past 1 1/2 weeks. Either we are getting other investors i.e. retailers buying or the noise on the street is getting out there and big houses are getting in. My thought as I see it is news will be coming and it will floor the heck out of all of ...more  
Comment by bogeyfree on Mar 06, 2021 2:41pm
Dunworkin2 wrote " still trying to understand our little rocket ship action without significant revenue news" my 2 cents on that is that there has been talks about Derm Tech lately and someone with really deep pockets has seen the POTENTIAL of MDX in regards with Derm Tech and has decided to invest. Unfortunately, potential alone won't do it.
Comment by Dunworkin2 on Mar 06, 2021 3:08pm
Ya, I'm not in the camp of comparing Mdx to that mammoth $1.6B USA company. From what I've read on this bullboard, the other company appears overvalued, but I haven't done any DD on it.  Our little rocket ship had some uninspirational Q3 numbers, so am looking forward to revenue news and/or Q4 to see what is moving the needle. "The Company reported revenue of $337,885 for ...more  
Comment by bogeyfree on Mar 06, 2021 4:54pm
I'm not that naive to be comparing MDX to Derm Tech, I'm just saying that someone could have seen a good potential with MDX. Potential is good but sales are better.
Comment by Swampcat27 on Mar 06, 2021 5:21pm
I tend to agree with your blurb , Rubberband.   Covid has put a little kink in the works , thats for sure.   I remain a MDX dreamer....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities